4582 — SymBio Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for SymBio Pharmaceuticals, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3,911	3,849	3,860	6,283	6,517
Net Total Accounts Receivable
Net Total Receivables	825	722	2,148	2,085	913
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,887	5,815	6,748	9,313	8,083
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	75.5	76.7	83.6	69	0
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5,274	6,275	8,453	10,433	8,170
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	872	1,615	1,518	1,924	957
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	874	1,617	1,707	1,927	960
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	4,400	4,657	6,746	8,506	7,210
Total Liabilities & Shareholders' Equity	5,274	6,275	8,453	10,433	8,170
Total Common Shares Outstanding